Related Experiment Video

Updated: Jun 29, 2026

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43
06:06

Constructing Mutants in Serotype 1 Streptococcus pneumoniae strain 519/43

Published on: September 11, 2020

Rise and persistence of global M1T1 clone of Streptococcus pyogenes

Ramy K Aziz1, Malak Kotb

  • 1Department of Microbiologyand Immunology, Cairo University, Cairo, Egypt. ramy.aziz@salmonella.org

Emerging Infectious Diseases
|October 2, 2008
PubMed

Insights

Group A Streptococcus infections reemerged due to bacterial strain diversification. A specific M1T1 strain evolved enhanced virulence through phage activity and host adaptation, driving severe invasive disease.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Epidemiology

Background:

  • The 1980s saw a resurgence of severe invasive group A streptococcal infections.
  • This reemergence highlighted the dynamic nature of infectious diseases and bacterial evolution.

Purpose of the Study:

  • To investigate the unique features driving the increased virulence and spread of a specific group A Streptococcus M1T1 subclone.
  • To understand the molecular mechanisms behind the resurgence of invasive group A streptococcal infections.

Main Methods:

  • Comparative genomic analysis of virulent and non-virulent strains.
  • Investigation of phage-mediated genetic exchange.
  • In vitro and in vivo assays to assess bacterial adaptation and host invasion.

Main Results:

  • A highly virulent M1T1 subclone of group A Streptococcus has emerged with distinct epidemiologic and virulence characteristics.
  • Bacterial diversification through phage mobilization and enhanced host environment sensing contribute to the subclone's increased virulence.
  • Selection favors fitter bacterial variants capable of efficient host tissue invasion.

Conclusions:

  • The resurgence of severe invasive group A streptococcal infections is linked to the evolution of hypervirulent bacterial strains.
  • Phage activity and adaptive capabilities are key factors in the emergence of pathogenic bacterial clones.
  • Understanding these evolutionary dynamics is crucial for controlling infectious disease outbreaks.

Related Concept Videos

Streptococcal Pharyngitis01:27

Streptococcal Pharyngitis

Streptococcal pharyngitis, commonly known as “strep throat,” is an acute infection of the oropharyngeal tissues caused by the Gram‑positive Group A Streptococcus (Streptococcus pyogenes). Transmission occurs primarily through respiratory droplets expelled during coughing, sneezing, or talking.Mechanisms of Host Entry and Immune EvasionUpon entering the host, S. pyogenes adheres to the mucosal epithelial cells of the pharynx via surface proteins, notably lipoteichoic acid and the antiphagocytic...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Determinants of Bacterial Pathogenicity and Virulence01:20

Determinants of Bacterial Pathogenicity and Virulence

Pathogenic bacteria employ a variety of strategies to establish infections, including the secretion of extracellular enzymes that act as potent virulence factors. These enzymes facilitate bacterial colonization of host tissues and help evade immune surveillance. By targeting structural components of host tissues and interfering with immune mechanisms, these enzymes play a pivotal role in disease progression.Extracellular Enzymes Facilitating Tissue Invasion: Several bacterial pathogens secrete...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...